Pharmacogenomics of intracellular methotrexate polyglutamates in patients’ leukemia cells in vivo-Reference-Cited by-同舟云学术

Pharmacogenomics of intracellular methotrexate polyglutamates in patients’ leukemia cells in vivo

Published:2020-11-09 Issue:12 Volume:130 Page:6600-6615
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Lopez-Lopez Elixabet^ORCID,Autry Robert J.^ORCID,Smith Colton,Yang Wenjian^ORCID,Paugh Steven W.,Panetta John C.^ORCID,Crews Kristine R.^ORCID,Bonten Erik J.,Smart Brandon,Pei Deqing,McCorkle J. Robert^ORCID,Diouf Barthelemy^ORCID,Roberts Kathryn G.,Shi Lei,Pounds Stanley^ORCID,Cheng Cheng,Mullighan Charles G.^ORCID,Pui Ching-Hon^ORCID,Relling Mary V.,Evans William E.^ORCID

Funder

NIH National Cancer Institute

NIH National Institute of General Medical Sciences Pharmacogenomics Research Network

Basque Government (Programa Posdoctoral de Perfeccionamiento de Personal Investigador doctor, Departamento de Educación, Política Lingüística y Cultura del Gobierno Vasco

NIH grant

American Recovery and Reinvestment Act supplement

National Cancer Institute Cancer Center Support Grant

American Lebanese Syrian Associated Charities

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/140797/files/pdf

Reference32 articles.

1. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries